Company Filing History:
Years Active: 2010
Title: Rita Blankenburg: Innovator in Pharmaceutical Composition
Introduction
Rita Blankenburg is a notable inventor based in Hamburg, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of semisolid preparations for various medical conditions. Her innovative work has led to the creation of a patent that addresses critical health issues.
Latest Patents
Rita Blankenburg holds a patent for the "Use of octenidine dihydrochloride in semisolid preparations." This invention relates to the use of octenidine dihydrochloride for manufacturing a semisolid pharmaceutical composition aimed at treating wounds, atopic dermatitides, infected eczemas, dermatomycoses, vaginal infections, acne, herpes, and controlling multidrug-resistant pathogens. The composition comprises from 0.005 to 5% by weight of octenidine dihydrochloride, showcasing her commitment to advancing medical treatments.
Career Highlights
Throughout her career, Rita has worked with prominent companies in the pharmaceutical industry. She has been associated with Air Liquide Santé, an international company, and Schülke & Mayr GmbH, where she has contributed her expertise in pharmaceutical innovations. Her work has been instrumental in developing effective treatments for various health conditions.
Collaborations
Rita has collaborated with notable professionals in her field, including Jorg Siebert and Mona Golombiewski. These collaborations have further enhanced her research and development efforts, leading to impactful innovations in pharmaceutical compositions.
Conclusion
Rita Blankenburg is a pioneering inventor whose work in pharmaceutical compositions has made a significant impact on healthcare. Her patent for the use of octenidine dihydrochloride exemplifies her dedication to improving treatment options for patients. Through her career and collaborations, she continues to contribute to advancements in the pharmaceutical industry.